Journal
CURRENT OPINION IN HEMATOLOGY
Volume 15, Issue 4, Pages 285-292Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MOH.0b013e328302f43a
Keywords
hematopoietic transplantation; peripheral blood stem cell mobilization; stem cells
Categories
Funding
- NHLBI NIH HHS [R01 HL079654-04, HL079654, R01 HL079654, HL69669, R01 HL069669, R01 HL069669-08, R01 HL096305] Funding Source: Medline
Ask authors/readers for more resources
Purpose of review Granulocyte colony-stimulating factor-mobilized peripheral blood stem cells are widely used to reconstitute hematopoiesis; however, preclinical and clinical studies show that improvements to this mobilization can be achieved. We discuss the development of new mobilizing regimens and evaluation of new findings on mobilized stem cell populations that may improve the utility and convenience of peripheral blood stem cell transplant. Recent findings Chemokines and their receptors regulate leukocyte trafficking, and altering chemokine signaling pathways mobilizes stem cells. In recent trials, combination use of the chemokine (C-X-C motif) receptor 4 antagonist AMD3100 and granulocyte colonystimulating factor mobilized more CD34(+) cells in fewer days than granulocyte colonystimulating factor alone and allowed more patients to proceed to autotransplant. In preclinical studies the chemokine GROG synergizes with granulocyte colonystimulating factor and when used alone or with granulocyte colony-stimulating factor mobilizes more primitive hematopoietic stem cells with less apoptosis, higher integrin activation, lower CD26 expression and enhanced marrow homing compared with granulocyte colony-stimulating factor. Hematopoietic stem cells mobilized by GROG or AMD3100 demonstrate superior engraftment and contribution to chimerism in primary and secondary transplant studies in mice, and peripheral blood stem cells mobilized by AMD3100 and granulocyte colony-stimulating factor in patients demonstrate enhanced engraftment capabilities in immunodeficient mice. Summary Alternate regimens differentially mobilize stem cell populations with unique intrinsic properties with the potential to expand the utility of hematopoietic transplantation. Continued mechanistic evaluation will be critical to our understanding of mechanisms of mobilization and their use in regenerative medicine.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available